-
Successful Conclusion of the 2023 CACLP Event by Bioantibody
From May 28th to 30th, the 20th China International Laboratory Medicine and Blood Transfusion Equipment Reagent Expo (CACLP) took place at the Greenland Expo Center in Nanchang, Jiangxi. Distinguished domestic and international experts, scholars, and enterprises specializing in the field of labor...Read more -
Bioantibody’s another 5 Rapid Test Kits Are Also On UK MHRA Whitelist Now!
Exciting news! Bioantibody has just received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for five of our innovative products. And so far we have a total of 11 products are on UK whitelist now. This is a significant milestone for our company, and we are thrilled...Read more -
Congratulations, Bioantibody Dengue Rapid Test Kits Have Been Listed On Malaysia Market Whitelist
We are thrilled to announce that our Dengue NS1 Antigen Rapid Test Kit and IgG/IgM Antibody Rapid Test Kits have been approved by the Malaysia Medical Device Authority. This approval allows us to sell these innovative and reliable products throughout Malaysia. Bioantibody Dengue NS1 Antigen Rapi...Read more -
Completed its first round of financing nearly 100 million yuan
Good News: Bioantibody has completed its first round of financing totaling nearly 100 million yuan. This financing was jointly led by Fang Fund, New Industry Investment, Guoqian Venture Investment, bondshine capital and Phoeixe Tree Investment. The funds will be used to speed up the in-depth layo...Read more -
Congratulations to Bioantibody for obtaining SGS ISO13485:2016 quality management system certificate
On September 20th 2022, Bioantibody has successfully obtained the ISO13485:2016 quality management system certificate issued by SGS, an internationally recognized testing, inspection and certification authority, after audit from each department. Prior to this, Bioantibod...Read more